BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20980520)

  • 1. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
    Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
    J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
    Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
    J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
    Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
    Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
    Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
    J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
    Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
    J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.
    Halemano K; Barrett BS; Li SX; Harper MS; Smith DS; Heilman KJ; Santiago ML
    PLoS One; 2013; 8(3):e60500. PubMed ID: 23533681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
    Barrett BS; Harper MS; Jones ST; Guo K; Heilman KJ; Kedl RM; Hasenkrug KJ; Santiago ML
    Retrovirology; 2017 Apr; 14(1):25. PubMed ID: 28415995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
    Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
    PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.
    Halemano K; Guo K; Heilman KJ; Barrett BS; Smith DS; Hasenkrug KJ; Santiago ML
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7759-64. PubMed ID: 24821801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
    Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
    Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.
    Halemano K; Barrett BS; Heilman KJ; Morrison TE; Santiago ML
    J Virol; 2015 Apr; 89(7):4011-4. PubMed ID: 25589647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
    Harper MS; Barrett BS; Smith DS; Li SX; Gibbert K; Dittmer U; Hasenkrug KJ; Santiago ML
    J Immunol; 2013 Feb; 190(4):1583-90. PubMed ID: 23315078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.
    Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML
    Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.
    Super HJ; Hasenkrug KJ; Simmons S; Brooks DM; Konzek R; Sarge KD; Morimoto RI; Jenkins NA; Gilbert DJ; Copeland NG; Frankel W; Chesebro B
    J Virol; 1999 Sep; 73(9):7848-52. PubMed ID: 10438878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
    Zhao W; Akkawi C; Mougel M; Ross SR
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.
    Okeoma CM; Petersen J; Ross SR
    J Virol; 2009 Apr; 83(7):3029-38. PubMed ID: 19153233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus.
    Hasenkrug KJ; Valenzuela A; Letts VA; Nishio J; Chesebro B; Frankel WN
    J Virol; 1995 Apr; 69(4):2617-20. PubMed ID: 7884913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice.
    Panoutsakopoulou V; Hunter K; Sieck TG; Blankenhorn EP; Blank KJ
    J Virol; 1999 Nov; 73(11):9232-6. PubMed ID: 10516031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.